- Profit after tax (consolidated)
- Rs 1,195.5 mn
- EPS
- Rs 1.95 +10.2%
- EPS a year earlier
- Rs 1.77
PSX Pharmaceuticals
SEARL The Searle Company Limited
Latest results: FY2026 · Jun 2026
FY2026 revenue Rs 36.8 bn (+28.7%), profit Rs 440.4 mn.
Last close · 13 Nov 2026
Rs 79.22 ▼ 0.31 (-0.39%)
▼ 23.5% 1 year
- Market cap
- —
- P/E
- 105.6×
- FY2026
- Sector 12.6× · higher
- P/B
- —
- FY2026
- Dividend yield
- 1.3%
- FY2026
- Payers 4.7% · lower
- ROE
- 1.3%
- FY2026
- Sector 21.7% · lower
- EPS
- Rs 0.75
- FY2026
- Book value / share
- —
- FY2026
Fundamentals
SEARL at a glance
Revenue · FY2026
Rs 36.8 bn
▲ 28.7% year on year
Profit attributable to shareholders · FY2026
Rs 440.4 mn
EPS – basic (Rs) · FY2026
Rs 0.75
Dividend per share (Rs) · FY2026
Rs 1.00
Net margin · FY2026
1.5%
-1.4 pts year on year
Debt to equity · FY2026
23.4%
-0.8 pts year on year
Price performance
SEARL returns
Close Rs 79.22
13 Nov 2026
| Period | Return | Rs | vs KSE-100 |
|---|---|---|---|
| MTD Month to date | +7.4% +0.5 pts vs KSE | +5.45 | +0.5 pts KSE +6.9% |
| 3M 3 months | −12.2% −10.9 pts vs KSE | −10.97 | −10.9 pts KSE −1.2% |
| 6M 6 months | −9.8% −16.1 pts vs KSE | −8.65 | −16.1 pts KSE +6.2% |
| YTD Year to date | −34.0% −36.2 pts vs KSE | −40.75 | −36.2 pts KSE +2.2% |
| FYTD Fiscal year to date | −16.2% −14.9 pts vs KSE | −15.32 | −14.9 pts KSE −1.4% |
| 1Y 1 year | −23.5% −34.3 pts vs KSE | −24.39 | −34.3 pts KSE +10.7% |
| Long term | |||
| 3Y 3 years | +73.4% +20.1% a year −141.3 pts vs KSE | +33.52 | −141.3 pts KSE +214.7% |
| 5Y 5 years | −30.6% −7.0% a year −319.4 pts vs KSE | −34.84 | −319.4 pts KSE +288.8% |
Price return from the last close before each period; the fiscal year ends 30 June. Dividends are not included.
The Searle Company Limited in brief
The Searle Company Limited (SEARL) reported revenue of Rs 36.8 bn for FY2026 (Jul 2025 – Jun 2026), up 28.7% from FY2025.
Profit attributable to shareholders was Rs 440.4 mn (EPS Rs 0.75), a net margin of 1.5%.
It declared a dividend of Rs 1.00 per share for FY2026.
Net debt stood at Rs 5.2 bn.
Return on equity was 1.3%.
Over the last five years revenue grew at a compound 7.0% a year.
At Rs 79.22 (close on 13 Nov 2026) the shares trade at 105.6× earnings (FY2026), with a dividend yield of 1.3%.
Scorecard vs Pharmaceuticals
14 companies- Growth
- Below average
- 12.6%
- Profitability
- Weak
- 1.5%
- Financial health
- Average
- 23.4%
- Valuation
- Weak
- 105.6×
- Dividends
- Average
- 1.3%
Ratings place the company in its sector: growth (3-year revenue growth), profitability (net margin; return on equity for banks, insurers and finance companies), financial health (debt to equity, industrial companies), valuation (P/E at today's price) and dividends (yield at today's price). Five dots = top fifth. Rated within the sector when at least four companies report the figure, otherwise against all PSX companies of the same type (marked vs PSX). Information, not investment advice.
Ownership
International funds holding SEARL
4 of the international funds we track list SEARL in their latest portfolio reports, shown as reported with each report's date.
- Funds holding
- 4
- Combined shares
- 6,332,013
- as reported
- Combined stake
- —
- of SEARL's shares
- Latest reports
- 1 added 0 reduced
- Jul 2014 – Apr 2026
| Fund | Shares | % of company | Weight in fund | Change | Report date |
|---|---|---|---|---|---|
| Ashmore Emerging Markets Frontier Equity Fund US Ashmore Investment Advisors Limited | 5,756,711 | 1.70% | ▲ +1,676,526 | Apr 2026 | |
| Polunin Emerging Markets Small Cap A USD Cap LU Carne Global Fund Managers Luxembourg SA | 274,702 | 0.38% | — | Jun 2025 older report | |
| AFC Asia Frontier (Non-US) A USD KY Asia Frontier Capital Ltd | 150,300 | 2.79% | — | Jul 2014 older report | |
| AFC Asia Frontier A USD KY Asia Frontier Capital Ltd | 150,300 | 2.79% | — | Jul 2014 older report |
As reported in each fund's latest portfolio report listing SEARL; funds report on their own dates, shown on each row. These are the international funds we track, not the full foreign shareholding. Updated monthly.
Corporate
SEARL announcements & payouts
- Profit after tax (unconsolidated)
- Rs 865.5 mn
- EPS
- Rs 1.47 -16.9%
- EPS a year earlier
- Rs 1.77
- Profit after tax (consolidated)
- Rs 535.7 mn
- EPS
- Rs 0.75
- EPS a year earlier
- Rs (2.73)
- Profit after tax (unconsolidated)
- Rs 4,003.2 mn
- EPS
- Rs 6.81
- EPS a year earlier
- Rs (2.73)
Book closure 15 Oct – 22 Oct 2026 · Buy by Mon 12 Oct (est.) for the payout
Financial highlights
SEARL financial results
| Rs bn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 * Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 | FY2021 Jul 2020 – Jun 2021 | FY2020 Jul 2019 – Jun 2020 | FY2019 * Jul 2018 – Jun 2019 | FY2018 * Jul 2017 – Jun 2018 | FY2017 Jul 2016 – Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36.8 | 28.6 | 29.4 | 25.8 | 29.9 | 26.2 | 20.5 | 18.1 | 16.1 | 13.3 |
| Gross profit | 19.1 | 14.1 | 13.7 | 11.4 | 13.1 | 12.2 | 9.7 | 8.6 | 8.3 | 7.0 |
| Operating profit | 6.3 | 3.4 | 4.8 | 3.7 | 5.5 | 6.0 | 4.2 | 3.1 | 3.4 | 2.9 |
| Profit after tax | 0.5 | 0.8 | 1.0 | (0.0) | 2.4 | 3.7 | 2.5 | 2.3 | 2.7 | 2.4 |
| Profit attributable to shareholders | 0.4 | (1.4) | (2.4) | 0.3 | 2.4 | 3.7 | 2.5 | 2.2 | 2.7 | 2.4 |
| EPS – basic (Rs) Rs | 0.75 | (2.38) | (4.31) | 0.68 | 5.03 | 8.11 | 5.84 | 5.24 | 6.28 | 5.50 |
| Dividend per share (Rs) Rs | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 | 1.24 | 1.24 | 2.16 | 3.53 |
| Total assets | 51.5 | 48.9 | 63.6 | 62.5 | 55.7 | 49.1 | 25.1 | 21.3 | 17.2 | 13.6 |
| Total equity | 34.3 | 32.9 | 34.4 | 31.7 | 30.7 | 26.1 | 16.0 | 13.5 | 11.5 | 9.8 |
| Total debt | 8.0 | 8.0 | 13.2 | 19.7 | 19.1 | 17.6 | 5.4 | 3.9 | 2.5 | 1.7 |
| Net cash from operating activities | 0.4 | (1.8) | 4.7 | (0.4) | (0.7) | 1.9 | (0.4) | (0.0) | 1.0 | 1.2 |
| Capital expenditure | (0.5) | (0.3) | (0.7) | (0.4) | (0.5) | (0.9) | (0.2) | (0.4) | (0.6) | (0.8) |
| Free cash flow (operating cash flow − capex) | (0.0) | (2.1) | 4.0 | (0.7) | (1.2) | 1.0 | (0.5) | (0.4) | 0.4 | 0.5 |
| Rs bn | TTM to Jun 2026 | Q4 FY2026 Apr – Jun 2026 | Q3 FY2026 Jan – Mar 2026 | Q2 FY2026 Oct – Dec 2025 | Q1 FY2026 Jul – Sep 2025 | Q4 FY2025 * Apr – Jun 2025 | Q3 FY2025 * Jan – Mar 2025 | Q2 FY2025 Oct – Dec 2024 | Q1 FY2025 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36.8 | 7.4 | 9.7 | 10.0 | 9.7 | 6.6 | 7.0 | 7.4 | 7.6 |
| Gross profit | 19.1 | 3.5 | 4.9 | 5.5 | 5.2 | 3.3 | 3.6 | 3.7 | 3.5 |
| Operating profit | 5.0 | (0.1) | 1.3 | 2.0 | 1.8 | 0.7 | 0.4 | 1.1 | 1.2 |
| Profit after tax | 0.5 | (1.8) | 0.5 | 0.9 | 0.9 | (0.1) | 0.2 | 0.5 | 0.3 |
| Profit attributable to shareholders | 0.4 | (1.8) | 0.5 | 0.9 | 0.9 | (1.1) | (0.4) | (0.4) | 0.4 |
| EPS – basic (Rs) Rs | — | — | 0.84 | 1.52 | 1.54 | (1.83) | (0.61) | (0.63) | 0.69 |
| Dividend per share (Rs) Rs | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total assets | 51.5 | 51.5 | 51.1 | 52.3 | 49.9 | 48.9 | 48.4 | 63.3 | 63.3 |
| Total equity | 34.3 | 34.3 | 35.2 | 34.7 | 33.8 | 32.9 | 32.0 | 34.5 | 34.9 |
| Total debt | 8.0 | 8.0 | 7.5 | 7.8 | 7.7 | 8.0 | 7.9 | 13.0 | 13.5 |
| Net cash from operating activities | 0.4 | (0.3) | (0.4) | 0.9 | 0.2 | 1.0 | (3.4) | 1.3 | (0.7) |
| Capital expenditure | (0.4) | (0.1) | (0.1) | (0.2) | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) |
| Free cash flow (operating cash flow − capex) | (0.0) | (0.4) | (0.4) | 0.7 | 0.1 | 1.0 | (3.5) | 1.2 | (0.8) |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 17 Oct 2026.
SEARL charts
Valuation
SEARL valuation at today's price
- Price to earnings (P/E)
- 105.6×
- EPS Rs 0.75 (FY2026)
- Price to book (P/B)
- —
- Book value — (FY2026)
- Dividend yield
- 1.3%
- DPS Rs 1.00 (FY2026)
- Earnings yield
- 0.9%
- EPS ÷ price
At the closing price of Rs 79.22 on 13 Nov 2026. P/E and P/B are not shown when earnings or book value are negative.
Sector peers
SEARL vs Pharmaceuticals companies
| Company | Market cap | P/E | P/B | Yield | ROE | 3-yr growth |
|---|---|---|---|---|---|---|
| SEARL | — | 105.6× | — | 1.3% | 1.3% | 12.6% |
| GLAXO | Rs 107.1 bn | 10.3× | 3.11× | 5.1% | 32.4% | 16.3% |
| ABOT | Rs 97.9 bn | 11.4× | 3.05× | 4.0% | 28.8% | 15.2% |
| HALEON | Rs 81.6 bn | 12.4× | 5.02× | 4.3% | 47.6% | 16.2% |
| HINOON | Rs 50.8 bn | 12.8× | 3.95× | 5.2% | 32.3% | 20.5% |
| AGP | Rs 43.8 bn | 11.7× | 2.92× | 5.1% | 25.9% | 26.0% |
| HPL | Rs 38.5 bn | 10.3× | 4.50× | 6.0% | 38.6% | 18.6% |
| FEROZ | Rs 15.8 bn | 16.1× | 1.19× | 1.5% | 7.6% | 27.9% |
| CPHL | Rs 14.5 bn | 18.3× | 1.34× | 0.0% | 7.3% | 4.3% |
Analyses & signals 2
Win rate 0.0% · 1 closed signal · average return -2.63%
-
Technical Signal Daily
SEARL: Short Term analysis 11th Nov. 206
Active Premium -
Technical Signal H1
SEARL The Searl Company short term analysis 20th Oct. 2026
SL hit -2.63% Pro
SEARL: frequently asked questions
What is SEARL's EPS?
The Searle Company Limited reported basic earnings per share of Rs 0.75 for FY2026 (Jul 2025 – Jun 2026).
What is SEARL's P/E ratio?
At the closing price of Rs 79.22 on 13 Nov 2026, SEARL trades at a P/E of 105.6× based on EPS of Rs 0.75 (FY2026).
Does SEARL pay dividends?
Yes. The Searle Company Limited declared a dividend of Rs 1.00 per share for FY2026. At Rs 79.22 that is a dividend yield of 1.3%.
What was SEARL's revenue and profit in FY2026?
The Searle Company Limited reported revenue of Rs 36.8 bn and profit attributable to shareholders of Rs 440.4 mn for FY2026 (Jul 2025 – Jun 2026).
How has SEARL's share price performed?
SEARL's share price is down 34.0% year to date (KSE-100: +2.2%), down 23.5% over one year (KSE-100: +10.7%) and down 30.6% over five years (KSE-100: +288.8%), as of 13 Nov 2026. These are price returns; dividends are not included.
Information only, not investment advice.